Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2004 09:00 ET | Source: Cobalis Corp

BioGentech Corp. Confirms Successful Termination of Its Unauthorized Listing on Berlin-Bremen Stock Exchange

IRVINE, Calif., May 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a publicly held Nevada corporation dedicated to developing and commercializing over-the-counter (OTC) products for the...
April 29, 2004 16:30 ET | Source: Cobalis Corp

BioGentech Announces ClinDatrix as CRO for Phase III Trials

IRVINE, Calif., April 29, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today that it has entered...
April 07, 2004 14:08 ET | Source: Cobalis Corp

BioGentech's Trading Symbol Erroneously Receives "E"

IRVINE, Calif., April 7, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, today announced that the letter "E" it...
April 01, 2004 18:52 ET | Source: Cobalis Corp

BioGentech Awarded Australian Patent Covering the Use of Cyanocobalamin (Vitamin B12) for the Treatment of Seasonal Allergies

IRVINE, Calif., April 1, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today that it has recently...
March 31, 2004 16:54 ET | Source: Cobalis Corp

BioGentech Finalizes Outsourcing Partnerships for Prehistin Phase III Clinical Trials

IRVINE, Calif., March 31, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today the finalization of...
March 26, 2004 17:20 ET | Source: Cobalis Corp

BioGentech Receives FDA Approval to Begin Phase III Clinical Trials

IRVINE, Calif., March 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergy medications, announced today the Division of...
March 26, 2004 08:30 ET | Source: Cobalis Corp

BioGentech Appoints Chairman and Additional Board Member

IRVINE, Calif., March 26, 2004 (PRIMEZONE) -- BioGentech Corp. (OTCBB:BGTH), a pharmaceutical company specializing in over-the-counter anti-allergic medications, announced today that its Board of...